References
- Blondeau JM. Expanded activity and utility of the new fluoroquinolones: a review. Clin. Ther. 21(1), 3–40; discussion 1 (1999).
- Blondeau JM. A review of the comparative in vitro activity of 12 antimicrobial agents with a focus on 4 new “respiratory quinolones”. J. Antimicrob. Chemother. 43(Suppl. B), 1–11 (1999).
- Davidson R, Cavalcanti R, Brunton JL et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N. Engl. J. Med. 346(10), 747–750 (2002).
- Blondeau JM, Hansen GT. Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features. Expert Opin. Pharmacother. 2(2), 317–335 (2001).
- Blondeau JM, Missaghi B. Gemifloxacin: a new fluoroquinolone. Expert Opin. Pharmacother. 5(5), 1117–1152 (2004).
- McDonald M, Blondeau JM. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. J. Cataract Refract. Surg. 36(9), 1588–1598 (2010).
- Hansen GT, Metzler K, Drlica K, Blondeau JM. Mutant prevention concentration of gemifloxacin for clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47(1), 440–441 (2003).
- Blondeau JM. Stat: Steps to antimicrobial therapy: a guide to management of infectious diseases. North American Compendium Inc., Hensell, ON, Canada (2011).
- Mandell LA, Wunderink RG, Anzueto A et al.; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44(Suppl. 2), S27–S72 (2007).
- Chow AW, Benninger MS, Brook I et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin. Infect. Dis. 54(8), e72–e112 (2012).
- Stevens DL, Bisno AL, Chambers HF et al.; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin. Infect. Dis. 41(10), 1373–1406 (2005).
- Hooton TM, Bradley SF, Cardenas DD et al.; Infectious Diseases Society of America. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin. Infect. Dis. 50(5), 625–663 (2010).
- Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin. Infect. Dis. 50(2), 133–164 (2010).
- Blondeau JM. Extended-spectrum β-lactamases. Semin. Respir. Infect. 16(3), 169–176 (2001).
- Mammeri H. Extended-spectrum cephalosporinases in Enterobacteriaceae. Antiinfect. Agents Med. Chem. 6, 71–82 (2007).
- Queenan AM Bush K. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20(3), 440–458 (2007).
- Ramphal R, Ambrose PG. Extended-spectrum β-lactamases and clinical outcomes: current data. Clin. Infect. Dis. 42(Suppl. 4), S164–S172 (2006).
- Blondeau JM. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option. Drugs 64(6), 611–628 (2004).